These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 36941570

  • 1. Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy.
    Guan J, Wang M, Zhao M, Ni W, Zhang M.
    BMC Nephrol; 2023 Mar 20; 24(1):60. PubMed ID: 36941570
    [Abstract] [Full Text] [Related]

  • 2. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
    Chai L, Cai K, Wang K, Luo Q.
    J Clin Lab Anal; 2021 Jun 20; 35(6):e23774. PubMed ID: 33951240
    [Abstract] [Full Text] [Related]

  • 3. DCR2, a Cellular Senescent Molecule, Is a Novel Marker for Assessing Tubulointerstitial Fibrosis in Patients with Immunoglobulin A Nephropathy.
    Chen J, Hu W, Xiao F, Lin L, Chen K, Wang L, Wang X, He Y.
    Kidney Blood Press Res; 2019 Jun 20; 44(5):1063-1074. PubMed ID: 31487717
    [Abstract] [Full Text] [Related]

  • 4. Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis.
    Sparding N, Genovese F, Rasmussen DGK, Karsdal MA, Neprasova M, Maixnerova D, Satrapova V, Frausova D, Hornum M, Bartonova L, Honsova E, Kollar M, Koprivova H, Hruskova Z, Tesar V.
    Nephrol Dial Transplant; 2022 May 25; 37(6):1099-1108. PubMed ID: 33914059
    [Abstract] [Full Text] [Related]

  • 5. Hyperuricemia and hypertriglyceridemia indicate tubular atrophy/interstitial fibrosis in patients with IgA nephropathy and membranous nephropathy.
    Liu B, Zhao L, Yang Q, Zha D, Si X.
    Int Urol Nephrol; 2021 Nov 25; 53(11):2321-2332. PubMed ID: 33895976
    [Abstract] [Full Text] [Related]

  • 6. Urinary angiostatin: a novel biomarker of kidney disease associated with disease severity and progression.
    Xia YY, Bu R, Cai GY, Zhang XG, Duan SW, Wu J, Wu D, Chen XM.
    BMC Nephrol; 2019 Apr 03; 20(1):118. PubMed ID: 30943905
    [Abstract] [Full Text] [Related]

  • 7. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy.
    Duan ZY, Bu R, Liang S, Chen XZ, Zhang C, Zhang QY, Li JJ, Chen XM, Cai GY.
    Front Immunol; 2024 Apr 03; 15():1326026. PubMed ID: 38426107
    [Abstract] [Full Text] [Related]

  • 8. Blood TGF-β1 and miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy.
    Bharti N, Agrawal V, Kamthan S, Prasad N, Agarwal V.
    Int Urol Nephrol; 2023 Jun 03; 55(6):1557-1564. PubMed ID: 36648741
    [Abstract] [Full Text] [Related]

  • 9. Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics.
    Wang D, Wu C, Chen S, Li Y, Wang L, Zhang Y, Li G.
    Front Immunol; 2023 Jun 03; 14():1117995. PubMed ID: 37020564
    [Abstract] [Full Text] [Related]

  • 10. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy.
    Wu C, Wang AY, Li G, Wang L.
    BMC Nephrol; 2018 Dec 29; 19(1):381. PubMed ID: 30594167
    [Abstract] [Full Text] [Related]

  • 11. Development and validation of a diagnostic nomogram to evaluate tubular atrophy/interstitial fibrosis of IgA nephropathy.
    Gan Y, Cai Y, Li J, Wu J, Zhang R, Han Q, Li W, Yang Q.
    Int J Med Sci; 2024 Dec 29; 21(4):674-680. PubMed ID: 38464822
    [Abstract] [Full Text] [Related]

  • 12. Decreased Expression of Urinary Mammalian Target of Rapamycin mRNA Is Related to Chronic Renal Fibrosis in IgAN.
    Cao Y, Wang Y, Liu Y, Zhu X, Zhang G, Wang S, Chen X, Liu D, Fu C.
    Dis Markers; 2019 Dec 29; 2019():2424751. PubMed ID: 31485275
    [Abstract] [Full Text] [Related]

  • 13. Urinary Periostin Excretion Predicts Renal Outcome in IgA Nephropathy.
    Hwang JH, Lee JP, Kim CT, Yang SH, Kim JH, An JN, Moon KC, Lee H, Oh YK, Joo KW, Kim DK, Kim YS, Lim CS.
    Am J Nephrol; 2016 Dec 29; 44(6):481-492. PubMed ID: 27802442
    [Abstract] [Full Text] [Related]

  • 14. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM.
    BMC Nephrol; 2017 Feb 15; 18(1):63. PubMed ID: 28201996
    [Abstract] [Full Text] [Related]

  • 15. Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy.
    Graham-Brown MP, Singh A, Wormleighton J, Brunskill NJ, McCann GP, Barratt J, Burton JO, Xu G.
    BMC Nephrol; 2019 Jul 11; 20(1):256. PubMed ID: 31296183
    [Abstract] [Full Text] [Related]

  • 16. Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis.
    Niu X, Zhang S, Shao C, Guo Z, Wu J, Tao J, Zheng K, Ye W, Cai G, Sun W, Li M.
    PeerJ; 2023 Jul 11; 11():e15125. PubMed ID: 37065697
    [Abstract] [Full Text] [Related]

  • 17. High levels of urinary complement proteins are associated with chronic renal damage and proximal tubule dysfunction in immunoglobulin A nephropathy.
    Wen L, Zhao Z, Wang Z, Xiao J, Birn H, Gregersen JW.
    Nephrology (Carlton); 2019 Jul 11; 24(7):703-710. PubMed ID: 30141239
    [Abstract] [Full Text] [Related]

  • 18. Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Zhang Q, Zhao Y, Luo Y, Guo S, Hou H, Han X, Zhou Y.
    Ren Fail; 2024 Dec 11; 46(1):2319326. PubMed ID: 38379319
    [Abstract] [Full Text] [Related]

  • 19. Use of liquid chromatography-tandem mass spectrometry to perform urinary proteomic analysis of children with IgA nephropathy and Henoch-Schönlein purpura nephritis.
    Fang X, Lu M, Xia Z, Gao C, Cao Y, Wang R, Wang M, Wu H.
    J Proteomics; 2021 Jan 06; 230():103979. PubMed ID: 32932007
    [Abstract] [Full Text] [Related]

  • 20. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy.
    Liu LL, Jiang Y, Wang LN, Liu N.
    Clin Exp Immunol; 2012 Aug 06; 169(2):148-55. PubMed ID: 22774989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.